
EUDA Health Lowers Streeterville Warrant Exercise Price to Align With Market Conditions

I'm PortAI, I can summarize articles.
EUDA Health Holdings has amended its warrant agreement with Streeterville Capital, reducing the exercise price from $4.00 to $2.00 per share and lowering the minimum share price for forced exercise from $6.00 to $3.00. This adjustment aims to align with market conditions and maintain flexibility in capital structure, without altering long-term strategic priorities. The latest analyst rating for EUDA stock is a Buy with a $6.00 price target. EUDA Health focuses on non-invasive healthcare services in Asia, particularly in the longevity sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

